PROVECTUS BIOPHARMACEUTICALS CEO Edward Pershing exercised Options covering 11,328 derivative securities across two transactions on 2026-09-04 at $0 per share. The transactions increased his reported derivative-security holdings to 2,936,277, giving investors the stated size, price and post-transaction ownership associated with the option exercise.

Key Highlights

  • The transactions occurred on 4 September 2026 at $0 per share.
  • Both transactions carried transaction code M, indicating option exercises.
  • Edward Pershing owned 2,936,277 derivative securities after the transactions.

PROVECTUS BIOPHARMACEUTICALS, INC. (OTC: PVCT) CEO Edward Pershing exercised options covering 11,328 derivative securities in two transactions. The exercise price was $0 per share.

Two Transactions Covered 11,328 Derivatives

The transactions took place on 4 September 2026. The combined total across the two transactions was 11,328 derivative securities.

Post-Transaction Holding

Edward Pershing’s reported derivative-security ownership stood at 2,936,277 after the transactions. The reported holding is the post-transaction figure associated with the option exercises.